Clinical study of patients with Alzheimer's disease under treatment with tacrine
García-López, M.T.; Guardado-Santervás, P.
Revista de Neurologia 32(4): 394-397
2001
ISSN/ISBN: 0210-0010 PMID: 11398762 Document Number: 529269
Document emailed within 1 workday
Related Documents
Manning, F.C. 1994: Tacrine therapy for the dementia of Alzheimer's disease American Family Physician 50(4): 819-826Burov, I.V.; Baĭmanov, T.D.; Maĭsov, N.I. 1992: Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators Biulleten' Eksperimental'noi Biologii i Meditsiny 113(4): 379-381
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Holt, J.; Stiltner, L.; Wallace, R.; Raetz, J. 2009: Clinical inquiries. do patients at high risk of Alzheimer's disease benefit from early treatment? Journal of Family Practice 58(6): 320-322
Turon-Estrada, A.; López-Pousa, S.; Gelada-Batlle, E.; Garre-Olmo, J.; Lozano-Gallego, M.; Hernández-Ferràndiz, M.; Fajardo-Tibau, C.; Morante-Muñoz, V.; Vilalta-Franch, J. 2003: Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period Revista de Neurologia 36(5): 421-424
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. 1997: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. the Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11(Suppl 2): S40-S44
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
El-Kammah, B.M.; el-Gafi, S.H.; el-Sherbiny, A.M.; Kader, M.M. 1975: Biochemical and clinical study for the role of tacrine as succinylcholine extender Journal of the Egyptian Medical Association 58(9-10): 559-567
Caban-Holt, A.; Bottiggi, K.; Schmitt, F.A. 2005: Measuring treatment response in Alzheimer's disease clinical trials Geriatrics Suppl: 3-8
Gavrilova, S.I.; Kolykhalov, I.V.; Fedorova, I.B.; Selezneva, N.D.; Kalyn, I.B.; Roshchina, I.F.; Odinak, M.M.; Emelin, A.Iu.; Kashin, A.V.; Gustov, A.V.; Antipenko, E.A.; Korshunova, I.A.; Davydova, T.A.; Messler, G. 2010: Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(1): 62-69
Antuono, P.G. 1995: Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group Archives of Internal Medicine 155(16): 1766-1772
Katz, I.R. 1998: Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias Journal of Clinical Psychiatry 59(Suppl 9): 38-44
Gil Gregorio, P.; Ramirez Diaz, S.P.; Ribera Casado, J.M. 2003: Dementia and Nutrition. Intervention study in institutionalized patients with Alzheimer disease Journal of Nutrition Health and Aging 7(5): 304-308
Unni, L.; Vicari, S.; Moriearty, P.; Schaefer, F.; Becker, R. 2000: The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate Methods and Findings in Experimental and Clinical Pharmacology 22(1): 57-61
Creţu, O.; Szalontay, A.S.; Chiriţă, R.; Chiriţă, V. 2008: Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 641-645
Henigsberg, N.; Kalember, P.; Hrabać, P.; Rados, M.; Bajs, M.; Rados, M.; Kovavić, Z.; Loncar, M.; Madzar, T. 2011: 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease Collegium Antropologicum 35(Suppl 1): 159-162
Demarin, V.; Podobnik, S.S.; Storga-Tomic, D.; Kay, G. 2004: Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study Drugs under Experimental and Clinical Research 30(1): 27-33
de Silva, H.A.; Pathmeswaran, A.; Gunatilake, S.B. 2005: Efficacy of rivastigmine on activities of daily living in Sri Lankan patients with Alzheimer disease and on improving caregiver burden: a prospective study Ceylon Medical Journal 50(3): 106-109